Equipe Vieillissement - Axe ARTERRE
Evaluation du risque et du traitement de l'athérosclose : vers l'épidémiologie des risques
Equipe constitutive du CERPOP, UMR 1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Jean FERRIÈRES •  chercheur


2024

  1. European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (Ferrières J
    collaborator). Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study. Lancet. 2024. 403(10421):55-66. doi: 10.1016/S0140-6736(23)01842-
  2. Gautier A, Picard F, Ducrocq G, Elbez Y, Fox KM, Ferrari R, Ford I, Tardif JC, Tendera M, Steg PG; CLARIFY investigators (Ferrières J collaborator). New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. Eur Heart J. 2024 Feb 1;45(5):366-375. doi: 10.1093/eurheartj/ehad556.
  3. Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL. Use of combination therapy is associated with improved LDL-cholesterol management: 1-year follow-up results from the European observational SANTORINI study. Eur J Prev Cardiol. 2024 Jun 11:zwae199. doi: 10.1093/eurjpc/zwae199.
  4. Fayol A, Schiele F, Ferrières J, Puymirat E, Bataille V, Tea V, Chamandi C, Albert F, Lemesle G, Cayla G, Weizman O, Simon T, Danchin N; FAST-MI Investigators. Association of Use and Dose of Lipid-Lowering Therapy Post Acute Myocardial Infarction With 5-Year Survival in Older Adults. Circ Cardiovasc Qual Outcomes. 2024 May;17(5):e010685. doi: 10.1161/CIRCOUTCOMES.123.010685.
  5. Marimpouy N, Guilbeau-Frugier C, Ferrières J, Balen F, Ramirez A, Delmas C, Biendel C, Beneyto M, Cherbi M, Foltran D, Mondoly P, Bongard V, Minville V, Delasnerie H, Rollin A, Maury P. The real incidence of sudden death: Fair estimations or futile speculations? Arch Cardiovasc Dis. 2024 Apr;117(4):244-248. doi: 10.1016/j.acvd.2024.01.00
  6. Reinikainen J, Kuulasmaa K, Oskarsson V, Amouyel P, Biasch K, Brenner H, De Ponti R, Donfrancesco C, Drygas W, Ferrières J, Grassi G, Grimsgaard S, Iacoviello L, Jousilahti P, Kårhus LL, Kee F, Linneberg A, Luksiene D, Mariño J, Moitry M, Palmieri L, Peters A, Piwonska A, Quarti-Trevano F, Salomaa V, Sans S, Schmidt CO, Schöttker B, Söderberg S, Tamosiunas A, Thorand B, Tunstall-Pedoe H, Vanuzzo D, Veronesi G, Woodward M, Lekadir K, Niiranen T. Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries. Eur J Prev Cardiol. 2024 Mar 27;31(5):569-577. doi: 10.1093/eurjpc/zwad359.
  7. NCD Risk Factor Collaboration (NCD-RisC) (Ferrières J, Bongard V collaborator). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2.
  8. Frances L, Croyal M, Ruidavets JB, Maraninchi M, Combes G, Raffin J, de Souto Barreto P, Ferrières J, Blaak EE, Perret B, Moro C, Valéro R, Martinez LO, Viguerie N. Identification of circulating apolipoprotein M as a new determinant of insulin sensitivity and relationship with adiponectin. Int J Obes (Lond). 2024 Mar 15. doi: 10.1038/s41366-024-01510-w. Epub ahead of print.

2023

  1. Di Castelnuovo A, Bonaccio M, Costanzo S, McElduff P, Linneberg A, Salomaa V, Männistö S, Ferrières J, Dallongeville J, Thorand B, Brenner H, Ferrario M, Veronesi G, Tamosiunas A, Grimsgaard S, Drygas W, Malyutina S, Söderberg S, Nordendahl M, Kee F, Grassi G, Dabboura S, Borchini R, Westermann D, Schrage B, Zeller T, Kuulasmaa K, Blankenberg S, Donati MB, Iacoviello L; MORGAM Study Investigators; de Gaetano G. Drinking alcohol in moderation is associated with lower rate of all-cause mortality in individuals with higher rather than lower educational level: findings from the MORGAM project. Eur J Epidemiol. 2023. Aug;38(8):869-881. doi: 10.1007/s10654-023-01022-3.
  2. Ferrières J, Bruckert E, Farnier M, Krempf M, Mourad JJ, Roux B, Schiele F. Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study. J Comp Eff Res. 2023 Apr;12(4):e220181. doi: 10.57264/cer-2022-0181.
  3. Gauthier V, Lafrance M, Barthoulot M, Rousselet L, Montaye M, Ferrières J, Huo Yung Kai S, Biasch K, Moitry M, Amouyel P, Dallongeville J, Meirhaeghe A. Long-term follow-up of survivors of a first acute coronary syndrome: Results from the French MONICA registries from 2009 to 2017. Int J Cardiol. 2023 May 1;378:138-143. doi: 10.1016/j.ijcard.2023.02.035.
  4. Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, De Bacquer D, Ballantyne CM, Bernabé-Ortiz A, Bobak M, Brenner H, Carrillo-Larco RM, de Lemos J, Dobson A, Dörr M, Donfrancesco C, Drygas W, Dullaart RP, Engström G, Ferrario MM, Ferrières J, de Gaetano G, Goldbourt U, Gonzalez C, Grassi G, Hodge AM, Hveem K, Iacoviello L, Ikram MK, Irazola V, Jobe M, Jousilahti P, Kaleebu P, Kavousi M, Kee F, Khalili D, Koenig W, Kontsevaya A, Kuulasmaa K, Lackner KJ, Leistner DM, Lind L, Linneberg A, Lorenz T, Lyngbakken MN, Malekzadeh R, Malyutina S, Mathiesen EB, Melander O, Metspalu A, Miranda JJ, Moitry M, Mugisha J, Nalini M, Nambi V, Ninomiya T, Oppermann K, d'Orsi E, Pająk A, Palmieri L, Panagiotakos D, Perianayagam A, Peters A, Poustchi H, Prentice AM, Prescott E, Risérus U, Salomaa V, Sans S, Sakata S, Schöttker B, Schutte AE, Sepanlou SG, Sharma SK, Shaw JE, Simons LA, Söderberg S, Tamosiunas A, Thorand B, Tunstall-Pedoe H, Twerenbold R, Vanuzzo D, Veronesi G, Waibel J, Wannamethee SG, Watanabe M, Wild PS, Yao Y, Zeng Y, Ziegler A, Blankenberg S. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023.389(14):1273-1285. doi: 10.1056/NEJMoa2206916.
  5. Honaryar MK, Allodji R, Jimenez G, Lapeyre M, Panh L, Camilleri J, Broggio D, Ferrières J, De Vathaire F, Jacob S. Early Development of Atherosclerotic Plaques in the Coronary Arteries after Radiotherapy for Breast Cancer (BACCARAT Study). J Cardiovasc Dev Dis. 2023.10(7):299. doi: 10.3390/jcdd10070299.
  6. Lu Y, Kiechl SJ, Wang J, Xu Q, Kiechl S, Pechlaner R; Global Pulse Wave Velocity Study Group (Ferrières J collaborator). Global distributions of age- and sex-related arterial stiffness: systematic review and meta-analysis of 167 studies with 509,743 participants. EBioMedicine. 2023 Jun;92:104619. doi: 10.1016/j.ebiom.2023.104619.
  7. Mourre F, Giorgi R, Gallo A, Boccara F, Bruckert E, Carrié A, Hankard R, Inamo J, Laboureau S, Moulin P, Valéro R, Béliard S; REFERCHOL Investigators (Ferrières J collaborator). Maternal Inheritance of Familial Hypercholesterolemia Gene Mutation Predisposes to Coronary Atherosclerosis as Assessed by Calcium Score in Adulthood. Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):e94-e103. doi: 10.1161/ATVBAHA.122.318119.
  8. NCD Risk Factor Collaboration (NCD-RisC) (Ferrières J collaborator). Diminishing benefits of urban living for children and adolescents' growth and development. Nature. 2023 Mar;615(7954):874-883. doi: 10.1038/s41586-023-05772-8.
  9. Peretti N, Vimont A, Mas E, Ferrières J, Tounian P, Lemale J, Boccara F, Di Filippo M, Charriere S, Moulin P, Poinsot P, Cottin Y, Ducluzeau PH, Dourmap C, Cariou B, Farnier M, Paillard F, Pradignac A, Yelnik C, Gallo A, Bruckert E, Beliard S; French Registry of Familial Hypercholesterolemia (REFERCHOL) investigators. Factors Predicting Statin Initiation During Childhood in Familial Hypercholesterolemia: Importance of Genetic Diagnosis. J Pediatr. 2023 Feb;253:18-24.e2. doi: 10.1016/j.jpeds.2022.08.041.
  10. Ray KK, Haq I, Bilitou A, Manu MC, Burden A, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL; SANTORINI Study Investigators. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. Lancet Reg Health Eur. 2023 Apr 5;29:100624. doi: 10.1016/j.lanepe.2023.100624.
  11. Toth PP, Ferrières J, Waters M, Mortensen MB, Lan NSR, Wong ND. Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention. Front Cardiovasc Med. 2023.10:1220017. doi: 10.3389/fcvm.2023.1220017.
  12. Weizman O, Tea V, Marijon E, Eltchaninoff H, Manzo-Silberman S, Leclercq F, Albert F, Bataille V, Drouet E, Naccache N, Puymirat E, Ferrières J, Schiele F, Simon T, Danchin N; FAST-MI investigators. Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Arch Cardiovasc Dis. 2023 Jul;116(6-7):324-334. doi: 10.1016/j.acvd.2023.05.006.

2022

  1. Abou Khalil Y, Marmontel O, Ferrières J, Paillard F, Yelnik C, Carreau V, Charrière S, Bruckert E, Gallo A, Giral P, Philippi A, Bluteau O, Boileau C, Abifadel M, Di-Filippo M, Carrié A, Rabès JP, Varret M. APOE Molecular Spectrum in a French Cohort with Primary Dyslipidemia. Int J Mol Sci. 2022 May 21;23(10):5792. doi: 10.3390/ijms23105792.
  2. Bérard E, Huo Yung Kai S, Coley N, Bongard V, Ferrières J. One-Year Impact of COVID-19 Lockdown-Related Factors on Cardiovascular Risk and Mental Health: A Population-Based Cohort Study. Int J Environ Res Public Health. 2022 Feb 1;19(3):1684. doi: 10.3390/ijerph19031684.
  3. Boini S, Bourgkard E, Ferrières J, Esquirol Y. What do we know about the effect of night-shift work on cardiovascular risk factors? An umbrella review. Front Public Health. 2022 Nov 23;10:1034195. doi: 10.3389/fpubh.2022.1034195.
  4. Degboé Y, Koch R, Zabraniecki L, Jamard B, Couture G, Ruidavets JB, Ferrieres J, Ruyssen-Witrand A, Constantin A. Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study. Front Med (Lausanne). 2022 May 19;9:785719. doi: 10.3389/fmed.2022.785719.
  5. Di Castelnuovo A, Costanzo S, Bonaccio M, McElduff P, Linneberg A, Salomaa V, Männistö S, Moitry M, Ferrières J, Dallongeville J, Thorand B, Brenner H, Ferrario M, Veronesi G, Pettenuzzo E, Tamosiunas A, Njølstad I, Drygas W, Nikitin Y, Söderberg S, Kee F, Grassi G, Westermann D, Schrage B, Dabboura S, Zeller T, Kuulasmaa K, Blankenberg S, Donati MB, de Gaetano G, Iacoviello L. Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population-based study. Addiction. 2022 Feb;117(2):312-325. doi: 10.1111/add.15593.
  6. Dillinger JG, Achkouty G, Albert F, Muller G, Labèque JN, Moisson L, Morelle JF, Cottin Y, Pezel T, Lim P, Aissaoui N, Schiele F, Ferrières J, Angoulvant D, Henry P, Puymirat E, Simon T, Danchin N; FAST-MI investigators. Deleterious synergistic effects of acute heart failure and diabetes mellitus in patients with acute coronary syndrome: Data from the FAST-MI Registries. Arch Cardiovasc Dis. 2022 May;115(5):264-275. doi: 10.1016/j.acvd.2022.02.004.
  7. Domain G, Chouquet C, Réant P, Bongard V, Vedis T, Rollin A, Mandel F, Delasnerie H, Voglimacci-Stephanopoli Q, Mondoly P, Beneyto M, Cariou E, Fournier P, Delmas C, Galinier M, Carrié D, Lafitte S, Lairez O, Ferrières J, Cochet H, Maury P. Relationships between left ventricular mass and QRS duration in diverse types of left ventricular hypertrophy. Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):560-568. doi: 10.1093/ehjci/jeab063.
  8. Errahmani MY, Locquet M, Spoor D, Jimenez G, Camilleri J, Bernier MO, Broggio D, Monceau V, Ferrières J, Thariat J, Boveda S, Kirova Y, Loap P, Langendijk JA, Crijns A, Jacob S. Association Between Cardiac Radiation Exposure and the Risk of Arrhythmia in Breast Cancer Patients Treated With Radiotherapy: A Case-Control Study. Front Oncol. 2022 Jul 4;12:892882. doi: 10.3389/fonc.2022.892882.
  9. Esquirol Y, Huo Yung Kai S, Carles C, Marquié JC, Fernandez A, Bongard V, Ferrières J. Exposure to environmental occupational constraints and all-cause mortality: Results for men and women from a 20-year follow-up prospective cohort, the VISAT study. Be aware of shift-night workers! Front Public Health. 2022 Nov 10;10:1014517. doi: 10.3389/fpubh.2022.1014517.
  10. Ferrières J, Farnier M, Bruckert E, Vimont A, Durlach V, Ferrari E, Gallo A, Boccara F, Ferrières D, Béliard S; French FH Registry group: French REgistry of Familial hypERCHOLesterolemia (REFERCHOL). Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia. Atheroscler Plus. 2022 Aug 17;50:17-24. doi: 10.1016/j.athplu.2022.08.001.
  11. Garcia R, Marijon E, Karam N, Narayanan K, Anselme F, Césari O, Champ-Rigot L, Manenti V, Martins R, Puymirat E, Ferrières J, Schiele F, Simon T, Danchin N. Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study. Eur Heart J. 2022 Dec 14;43(47):4887-4896. doi: 10.1093/eurheartj/ehac579.
  12. Ghaleb Y, Elbitar S, Philippi A, El Khoury P, Azar Y, Andrianirina M, Loste A, Abou-Khalil Y, Nicolas G, Le Borgne M, Moulin P, Di-Filippo M, Charrière S, Farnier M, Yelnick C, Carreau V, Ferrières J, Lecerf JM, Derksen A, Bernard G, Gauthier MS, Coulombe B, Lütjohann D, Fin B, Boland A, Olaso R, Deleuze JF, Rabès JP, Boileau C, Abifadel M, Varret M. Whole Exome/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia. Metabolites. 2022 Mar 18;12(3):262. doi: 10.3390/metabo12030262.
  13. Gauthier V, Montaye M, Ferrières J, Kai SHY, Biasch K, Moitry M, Amouyel P, Dallongeville J, Meirhaeghe A. Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries. Int J Cardiol. 2022 Aug 15;361:103-108. doi: 10.1016/j.ijcard.2022.05.040.
  14. Gbokou S, Biasch K, Dallongeville J, Kai SHY, Montaye M, Amouyel P, Meirhaeghe A, Ferrières J, Moitry M. Trends in in-hospital and out-of-hospital Coronary Heart Disease mortality in French registries during the period 2000 to 2016. Ann Epidemiol. 2022 Feb 26:S1047-2797(22)00025-4. doi: 10.1016/j.annepidem.2022.02.004.
  15. Honaryar MK, Allodji R, Ferrières J, Panh L, Locquet M, Jimenez G, Lapeyre M, Camilleri J, Broggio D, de Vathaire F, Jacob S. Early Coronary Artery Calcification Progression over Two Years in Breast Cancer Patients Treated with Radiation Therapy: Association with Cardiac Exposure (BACCARAT Study). Cancers (Basel). 2022 Nov 22;14(23):5724. doi: 10.3390/cancers14235724.
  16. Huo Yung Kai S, Ferrières J, Rossignol M, Bouisset F, Herry J, Esquirol Y. Prevalence and determinants of return to work after various coronary events: meta-analysis of prospective studies. Sci Rep. 2022 Sep 12;12(1):15348. doi: 10.1038/s41598-022-19467-z.
  17. Kai SHY, Ferrières J, Rossignol M, Bouisset F, Herry J, Esquirol Y. Prevalence and determinants of return to work after various coronary events: meta-analysis of prospective studies. Sci Rep. 2022 Sep 12;12(1):15348. doi: 10.1038/s41598-022-19467-z.
  18. Lapébie FX, Bongard V, Lacroix P, Aboyans V, Constans J, Boulon C, Messas E, Thomas-Delecourt F, Rosenbaum D, Ferrières J, Bura-Rivière A. Mortality, Cardiovascular and Limb Events in Patients With Symptomatic Lower Extremity Artery Disease and Diabetes. Angiology. 2022 Jul;73(6):528-538. doi: 10.1177/00033197211050144.
  19. Lemesle G, Puymirat E, Bonello L, Simon T, Steg PG, Ferrières J, Schiele F, Fauchier L, Henry P, Schurtz G, Ninni S, Lamblin N, Bauters C, Danchin N. Compared impact of diabetes on the risk of heart failure from acute myocardial infarction to chronic coronary artery disease. Diabetes Metab. 2022 Jan;48(1):101265. doi: 10.1016/j.diabet.2021.101265.
  20. Machta S, Gauthier V, Ferrières J, Montaye M, Huo Yung Kai S, Gbokou S, Biasch K, Moitry M, Amouyel P, Dallongeville J, Meirhaeghe A. Comparison of clinical profiles and care for patients with incident versus recurrent acute coronary syndromes in France: Data from the MONICA registries. PLoS One. 2022 Feb 14;17(2):e0263589. doi: 10.1371/journal.pone.0263589.
  21. Panh L, Ferrières J. The forgotten link between atherosclerosis and bone disease. Arch Cardiovasc Dis. 2022 Oct;115(10):488-489. doi: 10.1016/j.acvd.2022.06.002. Epub 2022 Sep 2. Erratum in: Arch Cardiovasc Dis. 2022 Dec;115(12):678.
  22. Panh L, Ferrières J. Erratum to "The forgotten link between atherosclerosis and bone disease" [Arch. Cardiovasc. Dis. 115 (2022) 488-489]. Arch Cardiovasc Dis. 2022 Dec;115(12):678. doi: 10.1016/j.acvd.2022.11.001. Epub 2022 Dec 1. Erratum for: Arch Cardiovasc Dis. 2022 Oct;115(10):488-489.
  23. Panh L, Vallet M, Tack I, Jaafar A, Lairez O, Ferrières J. Does diet influence coronary atherosclerosis via the acid-base balance? Arch Cardiovasc Dis. 2022 Jan;115(1):60-62. doi: 10.1016/j.acvd.2021.11.001.
  24. Rosberg V, Vishram-Nielsen JK, Kristensen AMD, Pareek M, Sehested TSG, Nilsson PM, Linneberg A, Palmieri L, Giampaoli S, Donfrancesco C, Kee F, Mancia G, Cesana G, Veronesi G, Grassi G, Kuulasmaa K, Salomaa V, Palosaari T, Sans S, Ferrieres J, Dallongeville J, Söderberg S, Moitry M, Drygas W, Tamosiunas A, Peters A, Brenner H, Schöttker B, Grimsgaard S, Biering-Sørensen T, Olsen MH. Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project. Prev Med Rep. 2022 Jan 27;26:101700. doi: 10.1016/j.pmedr.2022.101700.
  25. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC Scientific Document Group (Ferrières J collaborator). 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022 Feb 19;29(1):5-115. doi: 10.1093/eurjpc/zwab154.
  26. Weizman O, Marijon E, Narayanan K, Boveda S, Defaye P, Martins R, Deharo JC, Laurent G, Klug D, Sadoul N, Hocini M, Mansencal N, Anselme F, Da Costa A, Maury P, Ferrières J, Schiele F, Simon T, Danchin N; FAST‐MI Program Investigators. Incidence, Characteristics, and Outcomes of Ventricular Fibrillation Complicating Acute Myocardial Infarction in Women Admitted Alive in the Hospital. J Am Heart Assoc. 2022 Sep 6;11(17):e025959. doi: 10.1161/JAHA.122.025959.

2021

  1. Bouisset F, Gerbaud E, Bataille V, Coste P, Puymirat E, Belle L, Delmas C, Cayla G, Motreff P, Lemesle G, Aissaoui N, Blanchard D, Schiele F, Simon T, Danchin N, Ferrières J; FAST-MI Investigators. Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI. J Am Coll Cardiol. 2021 Sep 28;78(13):1291-1305. doi: 10.1016/j.jacc.2021.07.039.
  2. Bouisset F, Ruidavets JB, Dallongeville J, Moitry M, Montaye M, Biasch K, Ferrières J. Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction. J Clin Med. 2021 Jan 7;10(2):180. doi: 10.3390/jcm10020180.
  3. Brunet T, Bonello L, Chamandi C, Tea V, Nallet O, Lhermusier T, Gallet R, Labèque JN, Albert F, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat E; FAST-MI investigators. Long-term mortality after ST-elevation myocardial infarction in the reperfusion and modern secondary prevention therapy era according to coronary artery disease extent: The FAST-MI registries. Arch Cardiovasc Dis. 2021 Oct;114(10):647-655. doi: 10.1016/j.acvd.2021.06.014.
  4. Bouisset F, Deney A, Ferrières J, Panagides V, Becker M, Riviere N, Yvorel C, Commeau P, Adjedj J, Benamer H, Bonnet G, Cayla G; MODIF registry investigators. Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay. Int J Cardiol. 2021 Dec 15;345:14-19. doi: 10.1016/j.ijcard.2021.10.020.
  5. Costa VL, Ruidavets JB, Bongard V, Perret B, Repetto E, Stathopoulou MG, Serra F, Benahmed M, Mauduit C, Grandjean V, Ferrières J, Martinez LO, Trabucchi M. Prediction of coronary heart disease incidence in a general male population by circulating non-coding small RNA sRNY1-5p in a nested case-control study. Sci Rep. 2021 Jan 19;11(1):1837. doi: 10.1038/s41598-021-81221-8.
  6. Desjobert E, Tea V, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat E; FAST-MI investigators. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries. Arch Cardiovasc Dis. 2021 Feb;114(2):88-95. doi: 10.1016/j.acvd.2020.06.003.
  7. Durlach V, Bonnefont-Rousselot D, Boccara F, Varret M, Di-Filippo Charcosset M, Cariou B, Valero R, Charriere S, Farnier M, Morange PE, Meilhac O, Lambert G, Moulin P, Gillery P, Beliard-Lasserre S, Bruckert E, Carrié A, Ferrières J, Collet X, Chapman MJ, Anglés-Cano E. Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA). Arch Cardiovasc Dis. 2021 Dec;114(12):828-847. doi: 10.1016/j.acvd.2021.10.009.
  8. EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (Ferrières J collaborator). Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet. 2021 Sep 7:S0140-6736(21)01122-3. doi: 10.1016/S0140-6736(21)01122-3.
  9. Elsahoryi NA, Neville CE, Patterson CC, Linden GJ, Moitry M, Biasch K, Kee F, Amouyel P, Bongard V, Dallongeville J, Ferrières J, Woodside JV. Association between overall fruit and vegetable intake, and fruit and vegetable sub-types and blood pressure: the PRIME study (Prospective Epidemiological Study of Myocardial Infarction). Br J Nutr. 2021 Mar 14;125(5):557-567. doi: 10.1017/S0007114520001518.
  10. Errahmani MY, Thariat J, Ferrières J, Panh L, 17.    Errahmani MY, Thariat J, Ferrières J, Panh L, Locquet M, Lapeyre-Mestre M, Guernec G, Bernier MO, Boveda S, Jacob S. Risk of pacemaker implantation after radiotherapy for breast cancer: A study based on French nationwide health care database sample. Int J Cardiol Heart Vasc. 2021 Dec 25;38:100936. doi: 10.1016/j.ijcha.2021.100936.
  11. Ferrières J, Banks V, Pillas D, Giorgianni F, Gantzer L, Lekens B, Ricci L, Dova-Boivin M, Chauny JV, Villa G, Désaméricq G. Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study. PLoS One. 2021 Aug 2;16(8):e0255345. doi: 10.1371/journal.pone.0255345.
  12. Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021 Dec 17;10(24):5938. doi: 10.3390/jcm10245938.
  13. Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021 Dec 17;10(24):5938. doi: 10.3390/jcm10245938.
  14. Gallo A, Pérez de Isla L, Charrière S, Vimont A, Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Moulin P, Bruckert E, Mata P, Béliard S; REFERCHOL and SAFEHEART investigators (Ferrières J collaborator). The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia. JACC Cardiovasc Imaging. 2021 Dec;14(12):2414-2424. doi: 10.1016/j.jcmg.2021.06.011.
  15. Gerbaud E, Bouisset F, Ferrières J. Late is not always too late for revascularization in late-presenting patients with ST-segment elevation myocardial infarction. Arch Cardiovasc Dis. 2021 Nov;114(11):691-693. doi: 10.1016/j.acvd.2021.10.001.
  16. Grimaldi-Bensouda L, Le Heuzey JY, Ferrières J, Leys D, Davy JM, Martinez M, Dialla O, Smadja D, Nighoghossian N, Benichou J, Nordon C, Touzé E, Abenhaim L; PGRx-Stroke and PGRx-Atrial Fibrillation Study Groups. Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors. Stroke. 2021 Oct;52(10):3121-3131. doi: 10.1161/STROKEAHA.120.032704.
  17. Gerbaud E, Bouisset F, Ferrières J. Late is not always too late for revascularization in late-presenting patients with ST-segment elevation myocardial infarction. Arch Cardiovasc Dis. 2021 Nov;114(11):691-693. doi: 10.1016/j.acvd.2021.10.001.
  18. Huo Yung Kai S, Ferrières J, Carles C, Turpin M, Lapébie FX, Dutheil F, Bura-Rivière A, Esquirol Y. Lower limb venous and arterial peripheral diseases and work conditions: systematic review. Occup Environ Med. 2021 Jan;78(1):4-14. doi: 10.1136/oemed-2019-106375.
  19. Lapébie FX, Aboyans V, Lacroix P, Constans J, Boulon C, Messas E, Ferrières J, Bongard V, Bura-Rivière A. Editor's Choice - External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry. Eur J Vasc Endovasc Surg. 2021 Sep;62(3):439-449. doi: 10.1016/j.ejvs.2021.05.028.
  20. Lapébie FX, Bongard V, Lacroix P, Aboyans V, Constans J, Boulon C, Messas E, Thomas-Delecourt F, Rosenbaum D, Ferrières J, Bura-Rivière A. Mortality, Cardiovascular and Limb Events in Patients With Symptomatic Lower Extremity Artery Disease and Diabetes. Angiology. 2021 Nov 26:33197211050144. doi: 10.1177/00033197211050144. Epub ahead of print.
  21. Lapébie FX, Bura-Rivière A, Lacroix P, Constans J, Boulon C, Messas E, Aboyans V, Ferrières J, Bongard V. Impact of angiotensin receptor blockers on mortality after hospitalization for symptomatic lower extremity artery disease. Eur Heart J Cardiovasc Pharmacother. 2021 Nov 3;7(6):463-474. doi: 10.1093/ehjcvp/pvaa026.
  22. Massy ZA, Kolla E, Ferrières J, Bruckert E, Lambert O, Mansencal N, Laville M, Frimat L, Fouque D, Combe C, Pecoits-Filho R, Stengel B, Liabeuf S; CKD-REIN Collaborators. Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort study. J Nephrol. 2021 Oct;34(5):1467-1477. doi: 10.1007/s40620-021-01086-y.
  23. Matta A, Bongard V, Bouisset F, Taraszkiewicz D, Rabès JP, Ferrières J. Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis. Med Sci Monit. 2021 May 7;27:e928784. doi: 10.12659/MSM.928784.
  24. McKay GJ, Lyner N, Linden GJ, Kee F, Moitry M, Biasch K, Amouyel P, Dallongeville J, Bongard V, Ferrières J, Gey KF, Patterson CC, Woodside JV. Association of low plasma antioxidant levels with all-cause mortality and coronary events in healthy middle-aged men from France and Northern Ireland in the PRIME study. Eur J Nutr. 2021 Aug;60(5):2631-2641. doi: 10.1007/s00394-020-02455-2.
  25. NCD Risk Factor Collaboration (NCD-RisC) (Ferrières J collaborator). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 2021 Mar 9;10:e60060. doi: 10.7554/eLife.60060.
  26. NCD Risk Factor Collaboration (NCD-RisC) (Ferrières J collaborator). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24. Erratum in: Lancet. 2022 Feb 5;399(10324):520. PMID: 34450083; PMCID: PMC8446938.
  27. Schiele F, Gale CP, Simon T, Fox KAA, Bueno H, Lettino M, Tubaro M, Puymirat E, Ferrières J, Ecarnot F, Danchin N, Meneveau N. The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries. Eur Heart J Acute Cardiovasc Care. 2021 Apr 8;10(2):207-215. . doi: 10.1093/ehjacc/zuab010.
  28. Surendran P, Feofanova EV, Lahrouchi N, Ntalla I, Karthikeyan S, Cook J, Chen L, Mifsud B, Yao C, Kraja AT, Cartwright JH, Hellwege JN, Giri A, Tragante V, Thorleifsson G, Liu DJ, Prins BP, Stewart ID, Cabrera CP, Eales JM, Akbarov A, Auer PL, Bielak LF, Bis JC, Braithwaite VS, Brody JA, Daw EW, Warren HR, Drenos F, Nielsen SF, Faul JD, Fauman EB, Fava C, Ferreira T, Foley CN, Franceschini N, Gao H, Giannakopoulou O, Giulianini F, Gudbjartsson DF, Guo X, Harris SE, Havulinna AS, Helgadottir A, Huffman JE, Hwang SJ, Kanoni S, Kontto J, Larson MG, Li-Gao R, Lindström J, Lotta LA, Lu Y, Luan J, Mahajan A, Malerba G, Masca NGD, Mei H, Menni C, Mook-Kanamori DO, Mosen-Ansorena D, Müller-Nurasyid M, Paré G, Paul DS, Perola M, Poveda A, Rauramaa R, Richard M, Richardson TG, Sepúlveda N, Sim X, Smith AV, Smith JA, Staley JR, Stanáková A, Sulem P, Thériault S, Thorsteinsdottir U, Trompet S, Varga TV, Velez Edwards DR, Veronesi G, Weiss S, Willems SM, Yao J, Young R, Yu B, Zhang W, Zhao JH, Zhao W, Zhao W, Evangelou E, Aeschbacher S, Asllanaj E, Blankenberg S, Bonnycastle LL, Bork-Jensen J, Brandslund I, Braund PS, Burgess S, Cho K, Christensen C, Connell J, Mutsert R, Dominiczak AF, Dörr M, Eiriksdottir G, Farmaki AE, Gaziano JM, Grarup N, Grove ML, Hallmans G, Hansen T, Have CT, Heiss G, Jørgensen ME, Jousilahti P, Kajantie E, Kamat M, Käräjämäki A, Karpe F, Koistinen HA, Kovesdy CP, Kuulasmaa K, Laatikainen T, Lannfelt L, Lee IT, Lee WJ; LifeLines Cohort Study, Linneberg A, Martin LW, Moitry M, Nadkarni G, Neville MJ, Palmer CNA, Papanicolaou GJ, Pedersen O, Peters J, Poulter N, Rasheed A, Rasmussen KL, Rayner NW, Mägi R, Renström F, Rettig R, Rossouw J, Schreiner PJ, Sever PS, Sigurdsson EL, Skaaby T, Sun YV, Sundstrom J, Thorgeirsson G, Esko T, Trabetti E, Tsao PS, Tuomi T, Turner ST, Tzoulaki I, Vaartjes I, Vergnaud AC, Willer CJ, Wilson PWF, Witte DR, Yonova-Doing E, Zhang H, Aliya N, Almgren P, Amouyel P, Asselbergs FW, Barnes MR, Blakemore AI, Boehnke M, Bots ML, Bottinger EP, Buring JE, Chambers JC, Chen YI, Chowdhury R, Conen D, Correa A, Davey Smith G, Boer RA, Deary IJ, Dedoussis G, Deloukas P, Di Angelantonio E, Elliott P; EPIC-CVD; EPIC-InterAct, Felix SB, Ferrières J, Ford I, Fornage M, Franks PW, Franks S, Frossard P, Gambaro G, Gaunt TR, Groop L, Gudnason V, Harris TB, Hayward C, Hennig BJ, Herzig KH, Ingelsson E, Tuomilehto J, Järvelin MR, Jukema JW, Kardia SLR, Kee F, Kooner JS, Kooperberg C, Launer LJ, Lind L, Loos RJF, Majumder AAS, Laakso M, McCarthy MI, Melander O, Mohlke KL, Murray AD, Nordestgaard BG, Orho-Melander M, Packard CJ, Padmanabhan S, Palmas W, Polasek O, Porteous DJ, Prentice AM, Province MA, Relton CL, Rice K, Ridker PM, Rolandsson O, Rosendaal FR, Rotter JI, Rudan I, Salomaa V, Samani NJ, Sattar N, Sheu WH, Smith BH, Soranzo N, Spector TD, Starr JM, Sebert S, Taylor KD, Lakka TA, Timpson NJ, Tobin MD; Understanding Society Scientific Group, van der Harst P, van der Meer P, Ramachandran VS, Verweij N, Virtamo J, Völker U, Weir DR, Zeggini E, Charchar FJ; Million Veteran Program, Wareham NJ, Langenberg C, Tomaszewski M, Butterworth AS, Caulfield MJ, Danesh J, Edwards TL, Holm H, Hung AM, Lindgren CM, Liu C, Manning AK, Morris AP, Morrison AC, O'Donnell CJ, Psaty BM, Saleheen D, Stefansson K, Boerwinkle E, Chasman DI, Levy D, Newton-Cheh C, Munroe PB, Howson JMM. Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nat Genet. 2021 May;53(5):762. doi: 10.1038/s41588-021-00832-z. Erratum for: Nat Genet. 2020 Dec;52(12):1314-1332.
  29. Tebani A, Sudrié-Arnaud B, Boudabous H, Brassier A, Anty R, Snanoudj S, Abergel A, Abi Warde MT, Bardou-Jacquet E, Belbouab R, Blanchet E, Borderon C, Bronowicki JP, Cariou B, Carette C, Dabbas M, Dranguet H, de Ledinghen V, Ferrières J, Guillaume M, Krempf M, Lacaille F, Larrey D, Leroy V, Musikas M, Nguyen-Khac E, Ouzan D, Perarnau JM, Pilon C, Ratzlu V, Thebaut A, Thevenot T, Tragin I, Triolo V, Vergès B, Vergnaud S, Bekri S. Large-scale screening of lipase acid deficiency in at risk population. Clin Chim Acta. 2021 Aug;519:64-69. doi: 10.1016/j.cca.2021.04.005.
  30. Vishram-Nielsen JKK, Kristensen AMD, Pareek M, Laurent S, Nilsson PM, Linneberg A, Greve SV, Palmieri L, Giampaoli S, Donfrancesco C, Kee F, Mancia G, Cesana G, Veronesi G, Grassi G, Kuulasmaa K, Salomaa V, Palosaari T, Sans S, Ferrieres J, Dallongeville J, Söderberg S, Moitry M, Drygas W, Tamosiunas A, Peters A, Brenner H, Grimsgaard S, Savallampi M, Olsen MH. Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women: The MORGAM Project. Hypertension. 2021 Apr;77(4):1076-1085. doi: 10.1161/HYPERTENSIONAHA.120.16354.
  31. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC Scientific Document Group (Ferrières J collaborator). 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
  32. Volle K, Delmas C, Ferrières J, Toulza O, Blanco S, Lairez O, Lhermusier T, Biendel C, Galinier M, Carrié D, Elbaz M, Bouisset F. Prevalence and Prognosis Impact of Frailty Among Older Adults in Cardiac Intensive Care Units. CJC Open. 2021 Mar 26;3(8):1010-1018. doi: 10.1016/j.cjco.2021.03.009.
Publications 2020 2019